SPOCK2 and cancer: T cells and macrophages are closely associated with clinical outcome in LUAD (Iglesia et al., 2016) and our analysis results suggested that a high level of SPOCK2 expression in LUAD may affect the prognosis of LUAD cancer patients partly due to TIICs, indicating that SPOCK2 may have potential applications in immunotherapy.